{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:38:55Z","timestamp":1792478335924,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J011342"],"award-info":[{"award-number":["2022J011342"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preoperative discrimination between endometriosis-associated ovarian cancer (EAOC) and benign ovarian endometrioma (OE) remains challenging because imaging findings overlap and CA125 is frequently elevated by benign pelvic inflammation. We hypothesized that EAOC is associated with a systemic immune-coagulation signature that could improve risk stratification beyond tumor markers alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed treatment-naive patients who underwent primary surgery for ovarian masses between January 2015 and February 2025. EAOC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200949) and OE (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009146) were confirmed histopathologically according to the Sampson\u2013Scott criteria. Preoperative laboratory indices obtained within 2 weeks before surgery included fibrinogen, albumin, absolute monocyte count (AMC), CA125, and HE4; the fibrinogen-to-albumin ratio (FAR) was calculated. A multivariable logistic regression model integrating age, menopausal status, AMC, FAR, CA125, and HE4 was developed as the CO-MHF nomogram. Supplementary data-driven analyses included least absolute shrinkage and selection operator (LASSO) logistic regression, Akaike information criterion (AIC)-based stepwise selection, and add-one\/drop-one marginal contribution analysis. Discrimination, calibration, and clinical utility were assessed by area under the receiver operating characteristic curve (AUC), bootstrap-derived confidence interval (CI), the Hosmer-Lemeshow test, and decision curve analysis (DCA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FAR and AMC were significantly higher in EAOC than in OE (median FAR 0.10 versus 0.07; median AMC 0.39 versus 0.31\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L). The CO-MHF model showed favorable internal discrimination (AUC 0.932, 95% CI 0.887\u20130.968), outperforming HE4 (0.835), FAR (0.786), CA125 (0.769), and AMC (0.657). At the Youden-derived threshold (0.468), sensitivity was 75.5% and specificity 95.9%, with a positive predictive value (PPV) of 86.0% and a negative predictive value (NPV) of 92.1%. Lower thresholds increased sensitivity to 85.7%\u201393.9% at the cost of reduced specificity. Supplementary data-driven analyses supported the predictor set: AIC-based stepwise selection identified the same variables, and LASSO retained all CO-MHF predictors. Calibration was acceptable (Hosmer\u2013Lemeshow\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.225), and DCA showed greater net benefit across a range of threshold probabilities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A mechanism-informed nomogram combining FAR and AMC with established tumor markers may improve preoperative risk stratification for EAOC. This host-response framework merits further evaluation in other malignancy-versus-inflammation diagnostic settings, although prospective multicenter validation and clinical threshold optimization remain necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-026-02205-8","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:53:31Z","timestamp":1784800411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic immune and coagulation amplifiers resolve diagnostic ambiguity in endometriosis-associated ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Li","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"10290","key":"2205_CR1","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J, Massingham SK, Raikou M. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182\u201393.","journal-title":"Lancet"},{"issue":"1","key":"2205_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13048-021-00940-8","volume":"15","author":"J Varga","year":"2022","unstructured":"Varga J, Reviczk\u00e1 A, H\u00e1kov\u00e1 H, \u0160vajdler P, Rabajdov\u00e1 M, Ostr\u00f3 A. Predictive factors of endometriosis progression into ovarian cancer. J Ovarian Res. 2022;15(1):5.","journal-title":"J Ovarian Res"},{"issue":"10276","key":"2205_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","volume":"397","author":"HS Taylor","year":"2021","unstructured":"Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839\u201352.","journal-title":"Lancet"},{"issue":"1","key":"2205_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiol.204371","volume":"303","author":"EA Sadowski","year":"2022","unstructured":"Sadowski EA, Thomassin-Naggara I, Rockall A, Maturen KE, Forstner R, Jha P, Nougaret S, Siegelman ES, Reinhold C. O-RADS MRI risk stratification system: guide for assessing adnexal lesions from the ACR O-RADS committee. Radiology. 2022;303(1):35\u201347.","journal-title":"Radiology"},{"key":"2205_CR5","doi-asserted-by":"crossref","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.","DOI":"10.1136\/bmj.m3773"},{"key":"2205_CR6","doi-asserted-by":"crossref","unstructured":"Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. bmj. 2022;379:e070750.","DOI":"10.1136\/bmj-2022-070750"},{"issue":"4","key":"2205_CR7","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.ijgc.2025.101634","volume":"35","author":"F Mezzapesa","year":"2025","unstructured":"Mezzapesa F, Dondi G, Coada CA, De Leo A, De Terlizzi F, Strigari L, Di Costanzo S, Ravegnini G, Santoro M, de Biase D. Two possible entities of endometriosis-associated ovarian cancer: correlated or incidental? Int J Gynecol Cancer. 2025;35(4):101634.","journal-title":"Int J Gynecol Cancer"},{"key":"2205_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12885-026-15980-w","volume":"26","author":"MH Beck","year":"2026","unstructured":"Beck MH, Kordowitzki P, Roser E, Trelinska-Finger A, Schoof E, Chinczewski L, Mechsner S, Sehouli J. Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: real-world evidence from an ESGO centre of excellence. BMC Cancer. 2026;26:495.","journal-title":"BMC Cancer"},{"issue":"1","key":"2205_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-022-01588-8","volume":"21","author":"JW Zhu","year":"2022","unstructured":"Zhu JW, Charkhchi P, Akbari MR. Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer. 2022;21(1):114.","journal-title":"Mol Cancer"},{"key":"2205_CR10","doi-asserted-by":"crossref","unstructured":"Xiao Y, Bi M, Guo H, Li M. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis. EBioMedicine. 2022;79:104001.","DOI":"10.1016\/j.ebiom.2022.104001"},{"issue":"3","key":"2205_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/humupd\/dmz047","volume":"26","author":"S-W Guo","year":"2020","unstructured":"Guo S-W. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. Hum Reprod Update. 2020;26(3):423\u201349.","journal-title":"Hum Reprod Update"},{"issue":"22","key":"2205_CR12","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1200\/JCO.2003.05.165","volume":"21","author":"N Goldenberg","year":"2003","unstructured":"Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003;21(22):4194\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2205_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","volume":"8","author":"S Massironi","year":"2023","unstructured":"Massironi S, Vigan\u00f2 C, Palermo A, Pirola L, Mulinacci G, Allocca M, Peyrin-Biroulet L, Danese S. Inflammation and malnutrition in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2023;8(6):579\u201390.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2205_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13048-019-0563-8","volume":"12","author":"W Yu","year":"2019","unstructured":"Yu W, Ye Z, Fang X, Jiang X, Jiang Y. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer. J ovarian Res. 2019;12(1):88.","journal-title":"J ovarian Res"},{"issue":"1","key":"2205_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","volume":"24","author":"Y Xie","year":"2025","unstructured":"Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q, Dong Z, Liu K. Inflammation in cancer: therapeutic opportunities from new insights. Mol Cancer. 2025;24(1):51.","journal-title":"Mol Cancer"},{"key":"2205_CR16","doi-asserted-by":"publisher","first-page":"101041","DOI":"10.1016\/j.drup.2023.101041","volume":"73","author":"H Wang","year":"2024","unstructured":"Wang H, Wang X, Zhang X, Xu W. The promising role of tumor-associated macrophages in the treatment of cancer. Drug Resist Updates. 2024;73:101041.","journal-title":"Drug Resist Updates"},{"issue":"6586","key":"2205_CR17","doi-asserted-by":"publisher","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, Esener S, Fitzgerald RC, Gambhir SS, Kuhn P. Early detection of cancer. Science. 2022;375(6586):eaay9040.","journal-title":"Science"},{"issue":"4","key":"2205_CR18","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380.","journal-title":"Lancet Oncol"},{"key":"2205_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jclinepi.2021.01.009","volume":"132","author":"M Van Smeden","year":"2021","unstructured":"Van Smeden M, Reitsma JB, Riley RD, Collins GS, Moons KG. Clinical prediction models: diagnosis versus prognosis. J Clin Epidemiol. 2021;132:142\u20135.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2205_CR20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani AC, Gonzalez-Ochoa E, Alqaisi H, Madariaga A, Bhat G, Rouzbahman M, Sneha S, Oza AM. Heterogeneity and treatment landscape of ovarian carcinoma. Nat reviews Clin Oncol. 2023;20(12):820\u201342.","journal-title":"Nat reviews Clin Oncol"},{"issue":"3","key":"2205_CR21","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.3390\/ijms14035367","volume":"14","author":"MJ Worley Jr","year":"2013","unstructured":"Worley MJ Jr, Welch WR, Berkowitz RS, Ng S-W. Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci. 2013;14(3):5367\u201379.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2205_CR22","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.3390\/ijms25084306","volume":"25","author":"SC Steinbuch","year":"2024","unstructured":"Steinbuch SC, L\u00fc\u00df A-M, Eltrop S, G\u00f6tte M, Kiesel L. Endometriosis-associated ovarian cancer: from molecular pathologies to clinical relevance. Int J Mol Sci. 2024;25(8):4306.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2205_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.2019191150","volume":"294","author":"RF Andreotti","year":"2020","unstructured":"Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, Bourne T, Brown DL, Coleman BG, Frates MC. O-RADS US risk stratification and management system: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020;294(1):168\u201385.","journal-title":"Radiology"},{"issue":"1","key":"2205_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"4","key":"2205_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics, 2018. Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"Cancer J Clin"},{"issue":"1","key":"2205_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target therapy. 2021;6(1):263.","journal-title":"Signal Transduct Target therapy"},{"issue":"4","key":"2205_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","volume":"23","author":"L Cassetta","year":"2023","unstructured":"Cassetta L, Pollard JW. A timeline of tumour-associated macrophage biology. Nat Rev Cancer. 2023;23(4):238\u201357.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2205_CR28","doi-asserted-by":"publisher","first-page":"hoac009","DOI":"10.1093\/hropen\/hoac009","volume":"2022","author":"CM Becker","year":"2022","unstructured":"Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, King K, Kvaskoff M, Nap A, Petersen K. ESHRE guideline: endometriosis. Hum Reprod open. 2022;2022(2):hoac009.","journal-title":"Hum Reprod open"},{"issue":"6","key":"2205_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345\u201359.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2205_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/ALN.0000000000004764","volume":"140","author":"P Arina","year":"2023","unstructured":"Arina P, Kaczorek MR, Hofmaenner DA, Pisciotta W, Refinetti P, Singer M, Mazomenos EB, Whittle J. Prediction of complications and prognostication in perioperative medicine: a systematic review and PROBAST assessment of machine learning tools. Anesthesiology. 2023;140(1):85.","journal-title":"Anesthesiology"},{"key":"2205_CR31","doi-asserted-by":"crossref","unstructured":"Collins GS, Moons KG, Dhiman P, Riley RD, Beam AL, Van Calster B, Ghassemi M, Liu X, Reitsma JB, Van Smeden M. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. bmj. 2024;385:e078378.","DOI":"10.1136\/bmj-2023-078378"},{"key":"2205_CR32","doi-asserted-by":"crossref","unstructured":"Riley RD, Ensor J, Snell KI, Debray TP, Altman DG, Moons KG, Collins GS. External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. bmj. 2016;353:i3140.","DOI":"10.1136\/bmj.i3140"},{"key":"2205_CR33","doi-asserted-by":"crossref","unstructured":"Wang M, Xu J, Cui J, Xu S, Wu Y. Prognostic modeling of endometriosis-associated ovarian cancer based on molecular signatures: a retrospective study. J Ovarian Res. 2025;19(1):35.","DOI":"10.1186\/s13048-025-01937-3"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02205-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02205-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02205-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:43:57Z","timestamp":1792475037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02205-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02205-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective cohort study was conducted at Zhongshan Hospital of Xiamen University and was approved by the Institutional Review Board. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the Helsinki declaration and its later amendments or comparable ethical standards. The requirement for informed consent was waived by the Institutional Review Board of Zhongshan Hospital of Xiamen University due to the retrospective nature of the study and the use of de-identified clinical data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"319"}}